Valiant Organics Limited cash flow falls to Rs 22.84 crore

Valiant Organics generated consolidated net operating cash flow of Rs 22.84 crore for the half year ended 30 September 2026, down from Rs 92.24 crore a year earlier, despite net profit rising to Rs 46.56 crore from Rs 13.86 crore. A Rs 79.61 crore cash outflow from trade receivables was the largest drag on cash conversion.

Why did Valiant Organics operating cash flow decline?

Valiant Organics reported a Rs 69.40 crore year-on-year decline in net cash flow from operating activities, to Rs 22.84 crore in the half year ended 30 September 2026 from Rs 92.24 crore in the comparable 2025 period. Cash generated from operations was Rs 28.03 crore, compared with Rs 92.24 crore a year earlier, while direct taxes paid were Rs 5.18 crore against nil in the prior-year period.

The main change was in trade receivables. Receivables absorbed Rs 79.61 crore of consolidated cash in the latest half year, whereas they released Rs 21.89 crore in the prior-year period. This Rs 101.50 crore swing exceeded the fall in operating cash flow, showing that profit growth did not translate into comparable cash generation during the period.

How much did Valiant Organics receivables and inventory increase?

Valiant Organics' consolidated trade receivables rose to Rs 320.33 crore at 30 September 2026 from Rs 243.31 crore at 31 March 2026. The balance-sheet increase is consistent with the Rs 79.61 crore receivables outflow recorded in the consolidated cash-flow statement, subject to classification and other movements within the statement.

Inventories stood at Rs 110.98 crore at 30 September 2026, compared with Rs 91.52 crore at 31 March 2026. The cash-flow statement records a Rs 19.45 crore inventory outflow, more than the Rs 8.39 crore outflow in the half year ended 30 September 2025. Together, trade receivables and inventories used Rs 99.06 crore of cash in the latest first half.

Other asset movements also used cash in the half year ended 30 September 2026. Other current assets consumed Rs 4.25 crore, other non-current assets consumed Rs 6.08 crore and financial assets consumed Rs 1.00 crore. These outflows were partly offset by a Rs 31.81 crore increase in trade payables and a Rs 10.34 crore increase in other financial liabilities.

Did Valiant Organics profit growth translate into higher operating profit?

Valiant Organics' consolidated net profit rose to Rs 46.56 crore in the half year ended 30 September 2026 from Rs 13.86 crore in the prior-year half, while profit before tax increased to Rs 61.56 crore from Rs 18.53 crore. Operating profit before working-capital changes also rose to Rs 95.10 crore from Rs 47.84 crore before receivables, inventory and other balance-sheet movements reduced cash generation.

Revenue from operations increased to Rs 535.76 crore from Rs 361.71 crore over the same comparison. The Speciality Chemical Division generated Rs 394.12 crore of first-half revenue, up from Rs 275.00 crore, while Pharma Division revenue increased to Rs 141.64 crore from Rs 86.71 crore. Both divisions therefore contributed to the Rs 174.04 crore increase in consolidated revenue.

The Speciality Chemical Division reported segment result before interest and tax of Rs 45.62 crore, compared with Rs 31.13 crore a year earlier. The Pharma Division recorded a Rs 26.25 crore segment result, compared with a Rs 2.29 crore loss in the preceding first half. Finance cost was broadly unchanged at Rs 10.31 crore, compared with Rs 10.30 crore.

What happened to Valiant Organics investing, financing and cash balances?

Valiant Organics used Rs 11.37 crore in consolidated investing activities in the half year ended 30 September 2026, against Rs 70.24 crore used in the previous year's first half. Purchases of fixed assets, including capital work-in-progress, were Rs 25.29 crore compared with Rs 12.49 crore, while net investment in subsidiaries and other entities produced a Rs 13.03 crore cash inflow versus a Rs 59.04 crore outflow a year earlier.

Financing activities used Rs 6.75 crore, compared with an outflow of Rs 23.08 crore in the corresponding 2025 half year. Valiant Organics repaid Rs 8.00 crore of short-term borrowings on a net basis, raised Rs 11.79 crore from long-term borrowings and paid Rs 10.31 crore of interest. Consolidated current borrowings were Rs 192.10 crore at 30 September 2026, down from Rs 200.10 crore at 31 March 2026.

Net cash and cash equivalents increased by Rs 4.72 crore during the half year, closing at Rs 6.52 crore on 30 September 2026 against an opening balance of Rs 1.79 crore. Total consolidated current assets rose to Rs 457.65 crore from Rs 352.23 crore at 31 March 2026, while current liabilities rose to Rs 386.24 crore from Rs 350.25 crore.

Conclusion

Valiant Organics recorded higher first-half revenue, operating profit and net profit for the half year ended 30 September 2026, but these gains did not result in higher operating cash flow. The Rs 79.61 crore receivables outflow and Rs 19.45 crore inventory outflow reduced net operating cash flow to Rs 22.84 crore despite Rs 95.10 crore of operating profit before working-capital changes.

The filing does not disclose a receivables-collection target, inventory target or capital-spending plan after 30 September 2026. The key item for subsequent disclosures is whether the Rs 320.33 crore receivables balance and Rs 110.98 crore inventory balance change, alongside the effect of Rs 25.29 crore spent on fixed assets and capital work-in-progress in the first half.